Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

network-1989146_960_720

Taking a look behind the scenes of Serialisation

February 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation

The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …
Feature
bi_microparts_image

Boehringer terminates Alzheimer’s candidate after Phase 2 failure

February 12, 2018 Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma

Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …
News
david_kendall

MannKind entices Lilly VP to CMO role

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma

It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …
News
fuji

Fujifilm partners with Takeda, stepping into regenerative medicine

February 9, 2018 Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical

Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …
News
peter_goldschmidt_web

Stada poaches Novartis exec for fifth CEO in two years

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment

Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …
Appointment
bob_hugin1

Celgene Executive Chairman Bob Hugin retires

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fresh from its acquisition of Juno Therapeutics, Celgene announced that its Executive Chairman Bob Hugin was to retire effective 5 …
Appointment
online_feature_image

New Year, new goals

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma

With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …
Feature
biogen_idec_hillerod_2008

Biogen halts Tysabri trial after failure in acute ischemic stroke

February 8, 2018 Research and Development Biogen, Tysabri, multiple sclerosis, pharma, stroke, trial failure

Biogen has halted its investigation into the efficacy of its humanised monoclonal antibody Tysabri (natalizumab) in the treatment of acute …
News
kenji

Astellas confirms Kenji Yasukawa as new President and CEO

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …
Appointment
arcturus_joseph-e-payne

CEO gets the axe: Arcturus relieve Payne of position

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical

Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …
Appointment

J&J’s apalutamide shows strength in non-metastatic prostate cancer

February 7, 2018 Research and Development J&J, JJ, Johnson & Johnson, pharma, prostate cancer

Johnson & Johnson unveiled new data at the ASCO Genitourinary Cancer symposium which demonstrated that its androgen receptor antagonist apalutamide …
News
array_biopharma

Array’s melanoma therapy blasts Roche’s out of water

February 7, 2018 Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …
News
allergan

Allergan bolsters skincare portfolio with Elastagen acquisition for $95 million

February 7, 2018 Research and Development, Sales and Marketing Allergan, Elastagen, M&A, MA, pharma

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …
News
flu

NHS tells doctors to order stronger vaccine for next winter

February 7, 2018 Medical Communications, Research and Development NHS, biotech, drugs, flu season, pharma, pharmaceutical

England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026